Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MAUSHMI N SHETH

Allopathic & Osteopathic Physicians Psychiatry & Neurology Clinical Neurophysiology

NPI
1124221718
CMS profile
6311
Location
FRISCO, TX

General Payments · PY2018–2024

$10,344.34

  • Reported across 449 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,058.87

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,042.15 34
Education $16.72 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $312.16 5
ABBVIE INC. $226.60 13
Grifols USA, LLC $163.23 1
ACADIA Pharmaceuticals Inc $93.94 4
Celgene Corporation $70.42 4
Biogen, Inc. $49.25 2
EMD Serono, Inc. $32.17 1
Averitas Pharma Inc. $29.56 1
SK Life Science, Inc. $25.39 1
Kedrion Biopharma, Inc. $23.57 1
CATALYST PHARMACEUTICALS, INC. $16.72 1
Kyowa Kirin, Inc. $15.86 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,540.85 91
PY2019 $1,276.21 84
PY2020 $1,014.72 52
PY2021 $3,274.15 74
PY2022 $950.92 51
PY2023 $1,228.62 62
PY2024 $1,058.87 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.56 01/12/2024 Food and Beverage Undisputed 01/23/2026 1106085472 CMS
ABBVIE INC. $17.09 01/24/2024 Food and Beverage Undisputed 01/23/2026 1106085474 CMS
ABBVIE INC. $19.89 01/29/2024 Food and Beverage Undisputed 01/23/2026 1106085476 CMS
ABBVIE INC. $27.99 01/31/2024 Food and Beverage Undisputed 01/23/2026 1106085478 CMS
ABBVIE INC. $19.97 03/20/2024 Food and Beverage Undisputed 01/23/2026 1106085480 CMS
ABBVIE INC. $13.37 04/02/2024 Food and Beverage Undisputed 01/23/2026 1106085482 CMS
ABBVIE INC. $6.82 04/29/2024 Food and Beverage Undisputed 01/23/2026 1106085484 CMS
ABBVIE INC. $19.38 06/25/2024 Food and Beverage Undisputed 01/23/2026 1106085486 CMS
ABBVIE INC. $12.28 09/06/2024 Food and Beverage Undisputed 01/23/2026 1106085488 CMS
ABBVIE INC. $1.39 09/06/2024 Food and Beverage Undisputed 01/23/2026 1106085490 CMS
ABBVIE INC. $22.96 09/23/2024 Food and Beverage Undisputed 01/23/2026 1106085492 CMS
ABBVIE INC. $30.38 10/31/2024 Food and Beverage Undisputed 01/23/2026 1106085494 CMS
ABBVIE INC. $15.52 11/08/2024 Food and Beverage Undisputed 01/23/2026 1106085496 CMS
ACADIA Pharmaceuticals Inc $26.67 04/02/2024 Food and Beverage Undisputed 01/23/2026 1147993346 CMS
ACADIA Pharmaceuticals Inc $27.48 07/03/2024 Food and Beverage Undisputed 01/23/2026 1147993350 CMS
ACADIA Pharmaceuticals Inc $25.29 09/03/2024 Food and Beverage Undisputed 01/23/2026 1147993354 CMS
ACADIA Pharmaceuticals Inc $14.50 10/11/2024 Food and Beverage Undisputed 01/23/2026 1147993358 CMS
Amgen Inc. $18.34 03/12/2024 Food and Beverage Undisputed 01/23/2026 1116117981 CMS
Amgen Inc. $130.10 04/25/2024 Food and Beverage Undisputed 01/23/2026 1116117987 CMS
Amgen Inc. $130.10 04/25/2024 Food and Beverage Undisputed 01/23/2026 1116117993 CMS
Amgen Inc. $15.73 07/18/2024 Food and Beverage Undisputed 01/23/2026 1116117999 CMS
Amgen Inc. $17.89 08/14/2024 Food and Beverage Undisputed 01/23/2026 1116118007 CMS
Averitas Pharma Inc. $29.56 03/22/2024 Food and Beverage Undisputed 01/23/2026 1133446106 CMS
Biogen, Inc. $20.90 03/26/2024 Food and Beverage Undisputed 01/23/2026 1104805489 CMS
Biogen, Inc. $28.35 09/12/2024 Food and Beverage Undisputed 01/23/2026 1104812197 CMS
CATALYST PHARMACEUTICALS, INC. $16.72 10/29/2024 Education Undisputed 01/23/2026 1144456028 CMS
Celgene Corporation $20.39 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101188337 CMS
Celgene Corporation $15.05 04/17/2024 Food and Beverage Undisputed 01/23/2026 1101188339 CMS
Celgene Corporation $16.74 08/19/2024 Food and Beverage Undisputed 01/23/2026 1101188365 CMS
Celgene Corporation $18.24 10/21/2024 Food and Beverage Undisputed 01/23/2026 1101188375 CMS
EMD Serono, Inc. $32.17 04/20/2024 Food and Beverage Undisputed 01/23/2026 1120237640 CMS
Grifols USA, LLC $163.23 10/24/2024 Food and Beverage Undisputed 01/23/2026 1124735805 CMS
Kedrion Biopharma, Inc. $23.57 08/21/2024 Food and Beverage Undisputed 01/23/2026 1125860799 CMS
Kyowa Kirin, Inc. $15.86 02/08/2024 Food and Beverage Undisputed 01/23/2026 1127037194 CMS
SK Life Science, Inc. $25.39 01/12/2024 Food and Beverage Undisputed 01/23/2026 1154146318 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.